Danaher Corporation vs Vanguard High Dividend Yield ETF — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Vanguard High Dividend Yield ETF trades at $158.75 (market cap $100.80B). The key difference: Danaher Corporation is the larger of the two by market cap, and Danaher Corporation pays a 0.74% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Vanguard High Dividend Yield ETF for 139 Days on average.
| DHR | VYM | |
|---|---|---|
Market Cap | $152.87B | $100.80B |
Volume | 5,228,698 | 908,176 |
Sector | Health | — |
52-Week High | $242.05 | $167.03 |
52-Week Low | $161.91 | $137.47 |
Typical Hold Time | 69 Days | 139 Days |
Enterprise Value | $175.08B | — |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
VYM trades at $158.25, up 0.51% today, with a bearish technical signal from moving averages. The ETF maintains consistent dividend distributions, with the next payment scheduled for September 2026. Recent news highlights VYM's position as a reliable dividend ETF, though some analysts suggest alternative portfolios may offer superior returns. The fund's broad diversification across nearly 600 holdings provides stability but faces criticism for including companies with recent dividend cuts.
VYM offers steady income with moderate yield but faces competition from higher-performing dividend ETFs. Key risks include exposure to companies with potential dividend reductions and underperformance relative to peer strategies. The fund's low expense ratio and diversification remain attractive for conservative income investors seeking reliable quarterly payments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →